Overall survival of patients with KRAS wild-type tumor treated with FOLFOX/FORFIRI±cetuximab as the first-line treatment for metastatic colorectal cancer: A meta-analysis

Por Yang, Ya-Fan, Wang, Gui-Ying, He, Jing-Li, Wu, Feng-Peng, Zhang, Yan-Ni
Publicado no Medicine (Baltimore) (2017)

Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV...

Por WU, FENG-PENG, WANG, JUN, WANG, HUI, LI, NA, GUO, YIN, CHENG, YUN-JIE, LIU, QING, YANG, XIANG-RAN
Publicado no Exp Ther Med (2015)